Glucosuria and all-cause mortality among general screening participants

[1]  Y. Yano,et al.  Glycohemoglobin not as predictive as fasting glucose as a measure of prediabetes in predicting proteinuria. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  M. Wakisaka,et al.  Sodium glucose cotransporter 2 in mesangial cells and retinal pericytes and its implications for diabetic nephropathy and retinopathy , 2017, Glycobiology.

[3]  M. Zheng,et al.  Renal tubular damage may contribute more to acute hyperglycemia induced kidney injury in non-diabetic conscious rats. , 2015, Journal of diabetes and its complications.

[4]  H. Yokoyama,et al.  Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[5]  D. Batlle,et al.  Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  R. DeFronzo,et al.  Renal, metabolic and cardiovascular considerations of SGLT2 inhibition , 2017, Nature Reviews Nephrology.

[7]  Merlin C. Thomas,et al.  Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. , 2016, Kidney international.

[8]  A. Tamakoshi,et al.  Fasting but not casual blood glucose is associated with pancreatic cancer mortality in Japanese: EPOCH-JAPAN , 2017, Cancer Causes and Control.

[9]  A Sekikawa,et al.  Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. , 1999, Diabetes care.

[10]  S. Kritchevsky,et al.  Metformin as a Tool to Target Aging. , 2016, Cell metabolism.

[11]  K. Iseki,et al.  Association of dipstick hematuria with all-cause mortality in the general population: results from the specific health check and guidance program in Japan , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  J. Loeffler,et al.  Familial renal glucosuria: SLC5A2 mutation analysis and evidence of salt-wasting. , 2006, Kidney international.

[14]  V. Basevi.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[15]  S. Selph,et al.  Screening for Type 2 Diabetes Mellitus: A Systematic Review for the U.S. Preventive Services Task Force , 2015, Annals of Internal Medicine.

[16]  K. Iseki,et al.  Budget impact analysis of chronic kidney disease mass screening test in Japan , 2014, Clinical and Experimental Nephrology.

[17]  Y. Ohashi,et al.  Risk factor profiles based on estimated glomerular filtration rate and dipstick proteinuria among participants of the Specific Health Check and Guidance System in Japan 2008 , 2012, Clinical and Experimental Nephrology.

[18]  L. Weinrauch,et al.  Screening for Type 2 Diabetes Mellitus , 2015, Annals of Internal Medicine.

[19]  S. Griffin,et al.  Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes , 2017, Diabetologia.

[20]  H. Yamada,et al.  Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice , 2014, PloS one.

[21]  S. Ito,et al.  Effect of Behavior Modification on Outcome in Early- to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized Trial , 2016, PloS one.

[22]  J. Skupień,et al.  Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes. , 2017, Kidney international.

[23]  M. Nangaku,et al.  Activation of hypoxia-inducible factors prevents diabetic nephropathy. , 2015, Journal of the American Society of Nephrology : JASN.

[24]  M. Nangaku,et al.  Observation period for changes in proteinuria and risk prediction of end‐stage renal disease in general population , 2018, Nephrology.

[25]  T. McMorrow,et al.  New developments concerning the proximal tubule in diabetic nephropathy: in vitro models and mechanisms. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  D. Maahs,et al.  Clinical Use of Continuous Glucose Monitoring in Pediatrics , 2017, Diabetes technology & therapeutics.

[27]  H. Parving,et al.  Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. , 2016, The New England journal of medicine.

[28]  K. Iseki,et al.  Mortality risk among screened subjects of the specific health check and guidance program in Japan 2008–2012 , 2017, Clinical and Experimental Nephrology.

[29]  Hemoglobin A1c Levels Predicts Acute Kidney Injury after Coronary Artery Bypass Surgery in Non-Diabetic Patients , 2017, Brazilian journal of cardiovascular surgery.

[30]  S. Tang,et al.  Diabetic nephropathy and proximal tubular damage. , 2015, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[31]  M. MaahsDavid,et al.  Clinical Use of Continuous Glucose Monitoring in Pediatrics. , 2017 .

[32]  Kenji Takahashi,et al.  Prevalence of Diabetes and Impaired Glucose Tolerance in Funagata Area, Japan , 1993, Diabetes Care.

[33]  T. Ninomiya,et al.  Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes , 2014, Clinical and Experimental Nephrology.

[34]  C. Wanner.  EMPA-REG OUTCOME: The Nephrologist's Point of View. , 2017, The American journal of medicine.

[35]  H. Y. Lin,et al.  Glycosuria and Renal Outcomes in Patients with Nondiabetic Advanced Chronic Kidney Disease , 2016, Scientific Reports.

[36]  Boris P. Kovatchev,et al.  Metrics for glycaemic control — from HbA1c to continuous glucose monitoring , 2017, Nature Reviews Endocrinology.

[37]  J. Coresh,et al.  Trends in Chronic Kidney Disease in China. , 2016, The New England journal of medicine.

[38]  K. Svärdsudd,et al.  A Model for Early Diagnosis of Type 2 Diabetes Mellitus in Primary Health Care , 1993, Diabetic medicine : a journal of the British Diabetic Association.

[39]  T. Nishino,et al.  Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[40]  G. Rossi,et al.  Diagnosis and Classification of Diabetes Mellitus The information that follows is based largely on the reports of the Expert Committee on the Diagnosis and Classification of Diabetes (Diabetes Care 20:1183–1197, 1997, and Diabetes Care 26:3160–3167, 2003). , 2008, Diabetes Care.

[41]  R. Guthrie.  Canagliflozin and cardiovascular and renal events in type 2 diabetes , 2018, Postgraduate medicine.

[42]  G. Curhan,et al.  Screening, monitoring, and treatment of albuminuria: Public health perspectives. , 2006, Journal of the American Society of Nephrology : JASN.

[43]  A. Tsapas,et al.  Empagliflozin , Cardiovascular Outcomes , and Mortality in Type 2 Diabetes , 2015 .